The other attraction has to be is that BXN has been awarded GMP Grade Certification. Many in the Gummy or Pastel Business work under a Food Manufacturing Regulatory Framework Being GMP Accredited demonstrates how much further up the ladder BXN are compared to other Industry Participants. The quality and consistency of the end products are produced at Pharmaceutical level with exacting standards and specific accurate dose delivery.
Coupled to this BXN stand alone with Licensed Regulatory Permission to manufacture Pharmaceutical Grade Psilocybin and well as Synthetic MDMA used for Laboratory Trialing , Ironically there is another ASX listed Entity who's sole offering is the intravenous delivery of Psilocybin , there MC is $46m.
Normally my wheelhouse is Biotech , many know I'm a fixed margin Trader and I hunt Catalysts / Phase II Sweetspots and generally take a position after SH have a tantrum surrounding CR's but here at BXN , these guys have invested in Plant and Machinery have successfully jumped through all of the regulatory hoops and are now well underway with delivering their Strategy , Happy to be corrected but their History looks extremely positive as they promoted their Strategy and overcame Milestones in a timely manner,,, in short these guys look to "Deliver"
The Margins gained from the transition from Flower to Pastel Product is massive no matter which way you look at it Circa $1.1m worth of Flower Processed into Pastels returns circa $11m worth of Retail Product. (1000%)
BXN have already established a position of the largest capable GMP grade Manufacturer of edibles in Australia with plenty of headroom and capability for additional processing with the current Plant and machinery at hand,, so growth for BXN does not bring the additional teething issues and the necessity to invest in more Machinery ,, looks to all be upside from here..
Feel free to add to this Thread , I'm sure some LTH here have more detailed insights to share... Glad to be on board NZT
BXN Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)